Sponsor or institution
Clinical trials and research at Haima Therapeutics, LLC
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $1.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A platelets-inspired nanoparticle to restore bleeding control for people on antiplatelet drugs
A new, platelet-inspired nanoparticle therapy aims to restore normal blood clotting in people taking antiplatelet medicines who are at risk of dangerous bleeding.
-
A new platelet-inspired helper to control bleeding for people on antiplatelet medicines
A new platelet-inspired technology aims to restore normal clotting in people who take antiplatelet drugs, helping reduce bleeding during surgery or trauma.
-
Commercialization of an intravenous hemostatic nanoparticle for bleeding management
A new nanoparticle-based treatment called SynthoPlate could help stop dangerous bleeding across many situations, from accidents to surgeries, by mimicking how natural platelets work.
-
New treatment to reduce bleeding in patients with low platelet counts
This study is testing a new type of treatment that uses tiny particles to help people with low platelet counts, like those undergoing chemotherapy or dealing with autoimmune disorders, by providing a better way to prevent excessive bleeding.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.